Sanofi: FDA to undertake priority review of Dupixent® (dupilumab) for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps

    NEXT STORY
    ERYTECH to Present at Cowen & Company 39th Annual Healthcare Conference Meeting
    PREV STORY
    European Commission approves Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Precision Therapeutics’ Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer

    author_avatar
    NASDAQ Market News

    BioFit Probiotic Review: Risky Scam or Real Customer Results (April 2021 Updates)

    author_avatar
    NASDAQ Market News

    CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

    COVINGTON, Ky., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CTI Clinical Trial and Consulting Services ...

    author_avatar
    NASDAQ Market News